O. Reerink

University Hospital Heidelberg

Papers

1

Total Citations

179

H-Index

1

About

Dr. O. Reerink is a leading surgical oncologist whose work has fundamentally advanced the treatment of esophageal cancer through rigorous clinical trials. Her primary research focuses on minimally invasive surgical techniques, particularly robot-assisted surgery, and their comparative effectiveness against traditional open procedures. Dr. Reerink’s landmark contribution is the ROBOT trial, a randomized controlled trial that systematically compared robot-assisted minimally invasive thoraco-laparoscopic esophagectomy with open transthoracic esophagectomy for resectable esophageal cancer. This seminal 2012 study, which has garnered 179 citations, provided critical evidence on the safety, feasibility, and oncologic outcomes of robotic approaches, helping to establish a new standard in surgical care. By demonstrating that minimally invasive techniques could achieve comparable radical resection while potentially reducing morbidity, her work has directly influenced surgical protocols worldwide. Dr. Reerink’s dedication to evidence-based surgical innovation has not only improved patient recovery but also paved the way for broader adoption of robotic technology in complex oncologic resections, making her a pivotal figure in modern esophageal cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
179
Total Citations
179
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial)
179 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: University Hospital Heidelberg

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago